Parkside Financial Bank & Trust: RXRX position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Parkside Financial Bank & Trust on RXRX, newest first. How the timeline and the estimate are built.
Parkside Financial Bank & Trust held 2,000 RXRX shares at 2026-06-30 per its 13F-HR filed 2026-09-04.
the latest 13F is the newest step
- period ended2026-06-3013F 2,000 sharesChange vs previous 13F -110 shares
<0.01% of the 13F portfolio, value $7,340.
13F-HR 0001398344-26-016613 filed by Parkside Financial Bank & Trust
Accepted , ingested - period ended2026-03-3113F 2,110 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $6,478.
13F-HR 0001398344-26-009088 filed by Parkside Financial Bank & Trust
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 2,110 sharesChange vs previous 13F -9 shares
<0.01% of the 13F portfolio, value $8,630.
13F-HR 0001398344-26-003149 filed by Parkside Financial Bank & Trust
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 2,119 sharesChange vs previous 13F +2,019 shares
<0.01% of the 13F portfolio, value $10,341.
13F-HR 0001455267-25-000009 filed by Parkside Financial Bank & Trust
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 100 sharesChange vs previous 13F -65 shares
<0.01% of the 13F portfolio, value $506.
13F-HR 0001398344-25-014655 filed by Parkside Financial Bank & Trust
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 165 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $873.
13F-HR 0001398344-25-008964 filed by Parkside Financial Bank & Trust
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).